溶液pH值对二嗪磷紫外光降解产物及降解途径的影响

在低压汞灯(253.7 nm)光照条件下, 研究了溶液pH值对农药二嗪磷光降解产物及降解途径的影响. 结果表明: 不同溶液pH值条件下二嗪磷的光降解均符合一级反应动力学, 其在中性(pH=7.0, k=0.0234 min^-1)和碱性(pH=10.0, k=0.0236 min^-1)条件下的光降解速率基本相同, 且略高于酸性(pH=4.0, k=0.0193 min^-1)时的光降解速率. 通过UPLC-ESI-MS/MS对降解产物测定分析发现: 溶液pH值显著地影响了二嗪磷光降解产物的种类及生成量. 溶液pH=4.0、7.0和10.0的二嗪磷溶液分别UV光照60 min时分别检出了五种、八种和六种主要的光降解产物, 且同一产物在不同pH值条件下的生成量存在显著差异. 结合MS和MS/MS质谱图信息, 推导出了二嗪磷主要光降解产物的分子结构, 并根据光降解产物种类及生成量随光照时间的变化关系提出了不同溶液pH值时二嗪磷的可能降解途径.     

盐酸去氯羟嗪和盐酸氯丙那林的毛细管电泳-电致化学发光法同时测定

基于盐酸去氯羟嗪和盐酸氯丙那林都能增强联吡啶钌的电致化学发光信号,建立了一种分离检测海珠喘息定片中盐酸去氯羟嗪和盐酸氯丙那林的毛细管电泳-电致化学发光新方法.考察了联吡啶钌浓度、检测电位、磷酸盐缓冲液(PBS)浓度及其pH值、进样电压和进样时间等实验条件对分离、检测体系的影响.在优化的实验条件下,海珠喘息定片中的盐酸去氯羟嗪和盐酸氯丙那林在4 min内可实现分离检测.其线性范围均为5×107～1 × 10-5mol/L(相关系数分别为0.998 4和0.999 0),检出限分别为1.05×10-7mol/L和6.98×10-8mol/L(S/N=3).     

利用HPLC-MS对精(口恶)唑禾草灵微生物降解途径的研究

产碱菌属H(Alcaligenes sp.H)以及其紫外诱变菌Huv均可降解精噁唑禾草灵,液相色谱显示二者具有某一相同的精噁唑禾草灵微生物降解产物;利用高效液相色谱-质谱联用技术(HPLC-MS),对上述精噁唑禾草灵微生物降解产物进行鉴定.结果表明:精噁唑禾草灵水解是降解菌Alcaligenes sp.H与Huv降解精噁唑禾草灵的公共降解途径之一,其产物为(R)-2-[4-(6-氯-1,3-苯并噁唑-2-基氧)苯氧基]丙酸和乙醇.     

利用HPLC-MS对精噁唑禾草灵微生物降解途径的研究

产碱菌属H(Alcaligenes sp.H)以及其紫外诱变菌Huv均可降解精噁唑禾草灵，液相色谱显示二者具有某一相同的精噁唑禾草灵微生物降解产物；利用高效液相色谱一质谱联用技术(HPLC—MS)，对上述精噁唑禾草灵微生物降解产物进行鉴定。结果表明：精噁唑禾草灵水解是降解菌Alcaligenes sp．H与Huv降解精噁唑禾草灵的公共降解途径之一，其产物为(R)-2-[4-(6-氯-1，3．苯并噁唑-2-基氧)苯氧基]丙酸和乙醇。     

用反相高效液相色谱法测定人体血浆中盐酸氟桂利嗪含量

采用反相高效液相色谱法以桂利嗪为内标测定人体血浆中盐酸氟桂利嗪的含量.以V甲醇:V乙腈:V缓冲液=58:20:22的体系为流动相,用hypersilBDSC8不锈钢色谱柱、紫外检测器(检测波长254nm),血浆样品经乙酸乙酯萃取处理后进样测定.血浆中盐酸氟桂利嗪的含量在5～300μg/L范围内与盐酸氟桂利嗪的峰面积和桂利嗪的峰面积之比呈线性关系(r=0.9997),方法对盐酸氟桂利嗪的平均回收率为83.3%～85.0%,检出限为3μg/L(S/N=3).用该法测定了12名单次口服30mg西比灵(盐酸氟桂利嗪)胶囊的健康志愿者血浆中盐酸氟桂利嗪含量.结果表明,该药在血浆中含量平均达峰时间为(2.67±0.91)h,平均峰质量浓度为(154.9±66.0)μg/L.该法适用于盐酸氟桂利嗪药代动力学的临床监测和研究.     

盐酸二氧丙嗪分子印迹电极的制备与性能研究

以邻苯二胺为功能单体,盐酸二氧丙嗪为模板分子,对盐酸二氧丙嗪分子印迹电极制备与性能进行了研究。建立了一种新的测定盐酸二氧丙嗪的电化学分析方法。用循环伏安法和差分脉冲伏安法法研究了该电极的选择性和灵敏度。该分子印迹电极对盐酸二氧丙嗪分子具有显著的催化还原和选择作用。在p H5.6的乙酸-乙酸钠缓冲溶液中,还原峰电流与盐酸二氧丙嗪浓度在0.01~1.0 mg/m L范围内呈良好的线性关系,检出限为0.005 mg/m L。方法可用于药剂中盐酸二氧丙嗪含量的测定。     

曙红Y共振光散射探针测定盐酸丙米嗪

在弱酸性介质中,盐酸丙米嗪与曙红Y依靠静电引力和疏水作用力形成离子缔合物,使曙红Y溶液的吸收光谱、荧光光谱和共振光散射光谱发生变化。其中以共振光散射法灵敏度最高。据此,建立了使用曙红Y作为共振光散射探针测定盐酸丙米嗪的新方法。研究了体系的吸收光谱、荧光光谱和共振光散射光谱特征。在最大散射峰364 nm处,测得盐酸丙米嗪的线性范围为0.025～2.5μg/mL,检测限为5.32 ng/mL,并将方法用于药物中盐酸丙米嗪含量的测定。     

铁氰化钾-钙黄绿素体系后化学发光反应测定盐酸硫利达嗪

报道了盐酸硫利达嗪在铁氰化钾-钙黄绿素化学发光反应体系中的后化学发光反应。优化了反应条件,并建立了一种利用后化学发光反应测定盐酸硫利达嗪的流动注射化学发光分析法。方法的检出限为2.0×10-7g/mL,对2.0×10-6g/mL盐酸硫利达嗪测定的相对标准偏差为2.0%(n=11),线性范围为5.0×10-7～5.0×10-5g/mL。该法已用于盐酸硫利达嗪片剂中盐酸硫利达嗪含量的测定,结果与药典方法测定值一致。     

菲在TiO2催化下的光降解研究

以汞灯为光源,TiO₂为催化剂,对菲的光催化降解途径进行了研究.将水溶性极小的菲预先吸附到TiO₂上之后,菲可以在紫外线的照射下发生快速、完全的矿化.通过GC-MS手段检测到一些中间产物,给出了菲光催化降解的详细途径.另外,研究了菲在表面活性剂十六烷基三甲基溴化铵(HTAB)的助溶下TiO₂催化的光降解过程,探讨了表面活性剂的浓度和溶液pH值对反应速率的影响.     

同步荧光测定法同时测定盐酸普萘洛尔和盐酸氟桂利嗪

提出了用同步荧光测定法同时测定盐酸普萘洛尔和盐酸氟桂利嗪。试验表明:荧光检测盐酸普萘洛尔的波长宜选定296nm、盐酸氟桂利嗪的波长宜选定263nm、波长差Δλ为50nm条件下进行同步扫描。盐酸普萘洛尔和盐酸氟桂利嗪的质量浓度分别在1.2×10-6～2.8×10-3g.L-1和2.0×10-5～3.6×10-3g.L-1范围内与荧光强度呈线性关系,检出限(3S/N)分别为3.2×10-7g.L-1和6.8×10-6g.L-1。方法用于混合样品中盐酸普萘洛尔与盐酸氟桂利嗪含量的同时测定,回收率在97.5%～101.1%和97.5%～101.7%之间。     

UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation

A validated ultra-high performance liquid chromatography (UHPLC) method has been proposed, validated and used for the determination of olopatadine hydrochloride degradation products in olopatadine 1 mg mL^?1 eye drops solution under the influence of two different sterilisation methods, heating and filtration, with good precision and accuracy. We found that the heat sterilization method yields a higher content of olopatadine hydrochloride degradation products in eye drops compared to unsterilized drug product or drug product sterilized by filtration, except for α-hydroxy olopatadine impurity, which remains stable with time and applied sterilization method. Contents of olopatadine related compound B shows a higher increase (from <0.005 to 0.044 %) when sterilised by heating than when subjected to aging and sterilization by filtration (increase up to 0.011 %). Similarly, total amount of all impurities is also increased from 0.13 to 0.49 % when the drug product is sterilised by heating instead of filtration (up to 0.39 %). Content of olopatadine related compound B and of all impurities is increased by aging, probably through thermal and oxidative degradation. Forced degradation studies were correlated with the sterilisation study and possible degradation pathways were identified. Olopatadine shows strong degradation under oxidative and moderate degradation under photolytic environment, with the olopatadine related compound B as the main degradation product. Sterilization of eye drops solution by filtration is recommended.     

Photodegradation Kinetics of Fexofenadine Hydrochloride Using a LC Method

The kinetics of photodegradation of the antihistamine fexofenadine hydrochloride using a stability-indicating high performance liquid chromatography (HPLC) method is demonstrated. The degradation was carried out in methanol and in water solutions, prepared from coated tablets, in quartz cells under UV light at 254 nm. The kinetics parameters of order of reaction and the rate constants of the degradation were determined for both solvents. The degradation process of fexofenadine hydrochloride in solutions can be described by second-order kinetics under the experimental conditions used in this study. The obtained results show that the HPLC method is satisfactory in the determination of the kinetics of degradation of fexofenadine hydrochloride in the presence of its photolytic degradation products.     

高效液相色谱法同时测定祛痘产品中6种抗生素及甲硝唑

建立了一种高效液相色谱-二极管阵列检测器(HPLC-DAD)同时测定祛痘产品中6种抗生素(盐酸美满霉素、土霉素、盐酸四环素、盐酸金霉素、盐酸多西环素和氯霉素)及甲硝唑的分析方法。样品用甲醇提取,采用Agilent ZORBAX SB-C18色谱柱(250 mm×4.6 mm, 5 μm)分离;以甲醇、乙腈和0.002 mol/L草酸为流动相进行梯度洗脱,流速0.8 mL/min;柱温20 ℃,检测波长268 nm,进样量10 μL,外标法定量。结果表明,6种抗生素及甲硝唑在1～30 mg/L范围内呈良好的线性关系,相关系数(r)均不低于0.9970;方法检出限为1.1～1.2 μg/g;高、中、低(5、10、20 mg/L) 3个添加水平下的回收率为91.9%～107.7%,相对标准偏差(RSD)为0.13%～1.74%。应用该方法对祛痘产品进行检验,15%的样品中检出甲硝唑。该方法具有灵敏、准确、快速、分离效果好的优点,适用于祛痘产品中6种抗生素及甲硝唑的检测。     

High Pressure Liquid Chromatographic Determination of Promethazine Hydrochloride in the Presence of its Thermal and Photolytic Degradation Products: A Stability Indicating Assay

Abstract

A stability indicating method has been developed for the quantitation of promethazine hydrochloride in the presence of its photolytic and thermal degradation products. Following a basic extraction with acetonitrile, promethazine is separated from its internal standard, promazine, and vehicle components by direct high performance liquid chromatography using ultraviolet detection (249 nm) and a stainless steel column 25 cm in length, 0.46 cm i.d. packed with octa-decyl silica 5μ in diameter. A linear relationship was obtained between peak height ratio (promethazine/promazine) and promethazine hydrochloride in water over the range 30–600 g/ml. The percent coefficient of variation of the assay is 0.8% and the recovery of promethazine hydrochloride from aqueous solutions is 99.7%. The photolytic degradation of promethazine hydrochloride does not follow simple first order kinetics. Potassium iodide and p-benzoquinone had a significant effect on the degradation rate of promethazine during the first 30 minutes of the photolytic degradation reaction. However, after one hour there is no apparent quenching effect on the photolytic degradation rate of promethazine hydrochloride in the presence of these quenchers.     

A Rapid Stability-Indicating LC Method for Ziprasidone Hydrochloride

A simple and rapid reversed-phase liquid chromatographic method was developed for the related substances determination and quantitative evaluation of ziprasidone hydrochloride, which is used as an antipsychotic agent. Forced degradation studies were performed on bulk sample of ziprasidone hydrochloride using acid, base, oxidative hydrolysis, thermal stress and photolytic degradation. Mild degradation of the drug substance was observed during thermal stress and considerable degradation observed during base hydrolysis. The chromatographic method was fine tuned using the samples generated from forced degradation studies. Good resolution between the peaks corresponds to synthetic impurities and degradation products from the analyte were achieved on YMC Pack Pro C18 column using the mobile phase consists of a mixture of 0.05% v/v of phosphoric acid in water and acetonitrile. The stressed test solutions were assayed against the qualified working standard of ziprasidone hydrochloride and the mass balance in each case was close to 99.7% indicating that the developed method was stability-indicating. Validation of the developed method was carried out as per ICH requirements.     

Identification tree based on fragmentation rules for structure elucidation of organophosphorus esters by electrospray mass spectrometry

Organophosphorus compounds have played important roles as pesticides, chemical warfare agents and extractors of radioactive material. Structural elucidation of phosphonates poses a particular challenge because their initial forms can be hydrolyzed, thus, degradation products may predominate in samples acquired in the field. The analysis of non‐volatile organophosphorus compounds and their degradation products is possible using electrospray tandem mass spectrometry ESI‐MS/MS. Here, we present a generic strategy that allows the unambiguous identification of substituents for two families of organophosphorus compounds: the phosphonates and phosphates. General fragmentation rules were deduced based on the study of decomposition pathways of 55 organophosphorus esters, including examples found in the literature. Multistage MS (MSⁿ) experiments at high resolution in a hybrid mass spectrometer provide accurate mass measurements, whereas collision‐induced dissociation experiments in a triple quadrupole give access to small fragment ions. The creation of a specific nomenclature for each possible structure of organophosphorus compound, depending on the alkyl side chain linked to the oxygen, was achieved by applying these fragmentation rules. This led to the creation of an ‘identification tree’ based upon the unique consecutive decomposition pathways uncovered for each individual compound. Hence, seven structural motifs were created that orient an unequivocal identification using the ‘identification tree’. Despite the similar structures of the ensemble of phosphate and phosphonate esters, distinct identifications based upon characteristic neutral losses and diagnostic fragment ions were possible in all cases. Copyright © 2013 John Wiley & Sons, Ltd.     

Comprehensive stability‐indicating high‐performance liquid chromatography coupled with diode array detection method for simultaneous determination of amprolium hydrochloride and ethopabate in powder dosage form for veterinary use

This research deals with the development of a stability‐indicating high‐performance liquid chromatography method for simultaneous determination of amprolium hydrochloride and ethopabate. To the best of our knowledge, no comprehensive stability‐indicating method has been reported for analysis of this mixture. Separation was achieved using Kromasil cyano column with gradient elution of the mobile phase composed of sodium hexane sulfonate solution and methanol. Quantification was based on measuring peak areas at 266 nm. Amprolium and ethopabate peaks eluted at retention times 10.42 and 18.53 min, respectively. The proposed procedure was validated with respect to system suitability, linearity, ranges, precision, accuracy, specificity, robustness, detection, and quantification limits. Linearity ranges for amprolium and ethopabate were 1.5–240 and 1–160 μg/mL, respectively. Analytes were subjected to stress conditions of hydrolysis, oxidation and thermal degradation. The proposed method enabled resolution of drugs from their forced‐degradation products and amprolium related substance (2‐picoline). Moreover, specificity was verified by resolution of the analytes from about 22 drugs used in antimicrobial veterinary products. The validated method was successfully applied to assay of the combined veterinary powder dosage form, additionally it was implemented in the accelerated stability study of the dosage form when stored for six months at 40°C and 75% relative humidity.     

Gas Liquid Chromatographic Determination of Promethazine Hydrochloride in Polyethylene Glycol Suppositories Using the Hall's Electrolytic Conductivity Detector

Abstract

A gas liquid chromatographic method using the Hall's electrolytic conductivity detector is described for the determination of promethazine hydrochloride in polyethylene glycol suppositories. This method is capable of distinguishing the intact drug from its thermal degradation products. A linear relationship between peak height ratio (promethazine/promazine) and promethazine hydrochloride concentration is found up to a concentration of 600 μg/ml. In the presence and absence of polyethylene glycol vehicle the recovery of promethazine hydrochloride is found to be 100.2 and 99.7 percent respectively. The percent coefficient of variation is 0.62 and 0.94 in the absence and presence of polyethylene glycol vehicle.     

Separation and identification of process‐related substances and degradation products in mycophenolate mofetil by liquid chromatography coupled with quadrupole‐time of flight mass spectrometry

Mycophenolate mofetil is an antiproliferative immunosuppressive agent. Since its clinical efficacy and safety highly depend on the quality, the stability, and impurity profiles of mycophenolate mofetil are paid ever‐increasing attention. However, there are few published studies reporting the complete characterization of both the process‐related substances and degradation products in mycophenolate mofetil. In the present study, a highly specific and efficient liquid chromatography coupled with quadrupole‐time of flight mass spectrometry method was developed for the separation and identification of all the potential impurities in mycophenolate mofetil. According to the ICH Q1A (R2) guideline, the forced degradation studies were conducted to elucidate the stability and degradation pathways of mycophenolate mofetil. A total of 15 related substances, including the process‐related substances and stress degradation products were characterized by the established hyphenated method, 11 of them have not been reported before. In view of the synthetic route and degradation pathways of mycophenolate mofetil, the origins and formation mechanisms of these related substances were discussed. Based on the obtained stability and impurity profiles, key points of the manufacturing process were proposed to deliver mycophenolate mofetil with high purity.     

Development and validation of a stability-indicating RP-HPLC method for determination of atomoxetine hydrochloride in tablets

This paper describes the development of a stability-indicating RP-HPLC method for the determination of atomoxetine hydrochloride (ATX) in the presence of its degradation products generated from forced decomposition studies. The drug substance was subjected to stress conditions of acid, base, oxidation, wet heat, dry heat, and photodegradation. In stability tests, the drug was susceptible to acid, base, oxidation, and dry and wet heat degradation. It was found to be stable under the photolytic conditions tested. The drug was successfully separated from the degradation products formed under stress conditions on a Phenomenex C18 column (250 x 4.6 mm id, 5 microm particle size) by using acetonitrile-methanol-0.032 M ammonium acetate (55 + 05 + 40, v/v/v) as the mobile phase at 1.0 mL/min and 40 degrees C. Photodiode array detection at 275 nm was used for quantitation after RP-HPLC over the concentration range of 0.5-5 microg/mL with a mean recovery of 100.8 +/- 0.4% for ATX. Statistical analysis demonstrated that the method is repeatable, specific, and accurate for the estimation of ATX. Because the method effectively separates the drug from its degradation products, it can be used as a stability-indicating method.